This article is more than 5 years old. Information may no longer be current.
KDIGO appoints new guideline development director
Click Here to Manage Email Alerts
Amy Earley has joined the Kidney Disease: Improving Global Outcomes staff as the organization’s new guideline development director.
Earley will oversee KDIGO’s guideline development program under the guidance of KDIGO Chief Scientific Officer Michael Cheung, according to a press release. The organization currently has two new guidelines in the pipeline and two guideline updates underway. Earley will work with the evidence review team at Cochrane Kidney and Transplant and with the four volunteer guideline work groups.
Earley was previously at Tufts Medical Center in Boston, working with both the Center for Guideline Development and Implementation, as well as the Center for Clinical Evidence Synthesis. At Tufts, she was involved in the evidence review for several KDIGO guidelines. She later joined the evidence review team at Brown University, while also serving as a senior research associate at two health economics and outcomes research consulting firms in the real world strategy and analytics, and metaresearch departments, respectively, according to the press release.
“It is an honor and a thrill to be appointed guideline development director,” Earley said in the release. “My hope is that I can bring both my methodological background and empirical insights in guideline development to the process to ensure and enhance the continued success and impact of KDIGO guidelines.”
Cheung said, “The pace of KDIGO guidelines is picking up and Amy will help us ensure that our volunteer work groups are well organized, efficient and focused on the best science. Amy will go right to work on our guidelines since she is well acquainted with the processes involved.”
Reference: